Phosphonate Polymers Suppress Virulence Without Killing Microbes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for pathogens often destroy beneficial microbes, leading to concerns about antibiotic resistance, particularly in surgical settings, and there is a need for methods that suppress virulence without eliminating all microbes.
Innovation Solution
The development of medical compositions containing phosphonate-containing polymers that suppress the expression of virulence factors without destroying beneficial bacteria, using polymers with a phosphonate group of formula —P(═O)(OR1)2 or its salts, which are more stable and resistant to enzymatic degradation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional antimicrobial treatments are used to eliminate pathogens, then pathogen destruction is achieved, but beneficial microbes are also destroyed leading to antibiotic resistance concerns
Solution Approach 1:
The invention extracts and targets specifically the virulence factors of pathogens using phosphonate-containing polymers, rather than eliminating all microbes. The polymer composition selectively suppresses virulence factor expression while preserving beneficial microbial populations, thereby achieving pathogen control without the harmful side effects of broad-spectrum antimicrobial treatments
Solution Approach 2:
The phosphonate-containing polymer applies a localized effect specifically on virulence factor expression in pathogenic bacteria. The treatment creates a differential outcome where only the harmful virulence properties are suppressed, while the beneficial microbes maintain their normal functions and populations
2Object-generated harmful factors
If phosphonate-containing polymers are used to suppress virulence, then virulence factor expression is reduced without destroying beneficial bacteria, but the polymer must be stable enough to resist enzymatic degradation
Solution Approach 1:
The invention modifies the chemical parameters of the polymer by incorporating phosphonate groups with specific structural characteristics (formula —P(═O)(OR1)2 where R1 is hydrogen, alkyl, aryl, aralkyl, or alkaryl). These parameter changes in the polymer structure provide resistance to enzymatic degradation while maintaining the ability to suppress virulence factor expression
Data Source
AI summary
Medical compositions and methods of suppressing microbial virulence are provided. By suppressing virulence, administration and/or application of the medical compositions can be used to prevent, mitigate, or treat a microbial infection. More specifically, the medical compositions include a phosphonate-containing polymer. The phosphonate-containing polymers can suppress the expression of various virulence factors without destroying all microbes that may be present.